US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 5.545
  • +1.195+27.47%
Trading May 13 14:34 ET
290.57MMarket Cap-505P/E (TTM)

Emergent BioSolutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
65.98%-62.6M
-504.99%-206.3M
-65.41%32.1M
181.08%60M
-633.33%-114.4M
-393.30%-184M
-110.65%-34.1M
-71.72%92.8M
-543.11%-74M
47.47%-15.6M
Net income from continuing operations
104.83%9M
-259.40%-760.5M
26.12%-49.5M
-215.62%-266.7M
-357.62%-258.1M
-4,932.43%-186.2M
-196.40%-211.6M
-137.66%-67M
-158.41%-84.5M
-1,326.09%-56.4M
Operating gains losses
----
---74.2M
---3.7M
--2M
----
----
----
----
----
----
Depreciation and amortization
-19.36%27.9M
-12.70%125.1M
-17.09%29.6M
-13.04%28M
-26.07%32.9M
11.97%34.6M
15.75%143.3M
22.26%35.7M
-1.53%32.2M
34.04%44.5M
Deferred tax
-159.57%-12.2M
68.88%-8.9M
90.39%-5.2M
-71.62%6.5M
-885.71%-5.5M
-347.37%-4.7M
-162.17%-28.6M
-219.16%-54.1M
502.63%22.9M
146.67%700K
Other non cash items
168.75%4.3M
163.36%34.5M
292.59%10.4M
-77.60%2.8M
405.13%19.7M
-23.81%1.6M
45.56%13.1M
93.86%-5.4M
-86.29%12.5M
3,800.00%3.9M
Change In working capital
-170.08%-97.5M
-3,247.62%-70.3M
-71.85%46.5M
195.46%65.2M
-608.25%-145.9M
53.95%-36.1M
98.55%-2.1M
28.16%165.2M
23.00%-68.3M
73.42%-20.6M
-Change in receivables
-2,023.08%-50M
-118.29%-21.6M
3.65%36.9M
574.34%72.1M
-3,430.00%-133.2M
-97.23%2.6M
829.01%118.1M
-63.86%35.6M
81.00%-15.2M
105.21%4M
-Change in inventory
85.34%-4.5M
101.05%600K
-43.98%25.6M
95.60%-1.2M
127.17%6.9M
38.72%-30.7M
14.26%-57.1M
631.40%45.7M
-225.81%-27.3M
-225.74%-25.4M
-Change in prepaid assets
-33.33%-6M
158.79%11.7M
108.33%30M
96.64%-500K
-375.00%-13.3M
72.89%-4.5M
-358.44%-19.9M
-76.96%14.4M
71.56%-14.9M
-136.84%-2.8M
-Change in payables and accrued expense
-332.50%-34.6M
31.90%-55.5M
-170.51%-42.2M
138.46%3M
-120.85%-8.3M
91.83%-8M
-1,098.53%-81.5M
-177.61%-15.6M
-118.62%-7.8M
304.10%39.8M
-Change in other working capital
-153.33%-2.4M
-114.36%-5.5M
-104.47%-3.8M
-164.52%-8.2M
105.52%2M
160.00%4.5M
160.70%38.3M
295.18%85.1M
84.42%-3.1M
-302.22%-36.2M
Cash from discontinued investing activities
Operating cash flow
65.98%-62.6M
-504.99%-206.3M
-65.41%32.1M
181.08%60M
-633.33%-114.4M
-393.30%-184M
-110.65%-34.1M
-71.72%92.8M
-543.11%-74M
47.47%-15.6M
Investing cash flow
Cash flow from continuing investing activities
28.48%-10.8M
155.68%212.3M
74.89%-11.4M
93.04%-18.9M
902.80%257.7M
53.11%-15.1M
-70.15%-381.3M
0.87%-45.4M
-392.03%-271.6M
52.09%-32.1M
Net PPE purchase and sale
28.48%-10.8M
55.44%-51.6M
51.69%-11.4M
54.84%-12.6M
61.06%-12.5M
53.11%-15.1M
48.33%-115.8M
48.47%-23.6M
49.46%-27.9M
52.09%-32.1M
Net business purchase and sale
----
--270.2M
--0
--0
----
----
--0
--0
--0
----
Net other investing changes
----
97.63%-6.3M
--0
----
----
----
---265.5M
---21.8M
----
----
Cash from discontinued investing activities
Investing cash flow
28.48%-10.8M
155.68%212.3M
74.89%-11.4M
93.04%-18.9M
902.80%257.7M
53.11%-15.1M
-70.15%-381.3M
0.87%-45.4M
-392.03%-271.6M
52.09%-32.1M
Financing cash flow
Cash flow from continuing financing activities
487.62%40.7M
-211.33%-535.7M
-98.67%4.7M
-118.75%-43M
-1,485.99%-486.9M
85.11%-10.5M
441.28%481.2M
420.42%353.1M
4,686.00%229.3M
-707.89%-30.7M
Net issuance payments of debt
589.29%41.1M
-196.31%-543.4M
-98.83%4.1M
-118.68%-42.9M
-5,807.14%-496.2M
1.18%-8.4M
1,671.59%564.2M
4,284.52%351.5M
4,200.00%229.6M
-47.37%-8.4M
Net common stock issuance
----
110.23%8.4M
200.00%200K
--0
----
----
22.55%-82.1M
99.81%-200K
--0
---24.4M
Proceeds from stock option exercised by employees
----
-64.00%1.8M
-75.00%500K
--0
----
----
-68.55%5M
-41.18%2M
--0
-19.35%2.5M
Net other financing activities
80.95%-400K
57.63%-2.5M
50.00%-100K
66.67%-100K
50.00%-200K
58.00%-2.1M
60.67%-5.9M
-120.00%-200K
84.21%-300K
66.67%-400K
Cash from discontinued financing activities
Financing cash flow
487.62%40.7M
-211.33%-535.7M
-98.67%4.7M
-118.75%-43M
-1,485.99%-486.9M
85.11%-10.5M
441.28%481.2M
421.00%353.1M
4,686.00%229.3M
-707.89%-30.7M
Net cash flow
Beginning cash position
-82.62%111.7M
11.50%642.6M
-63.57%87.8M
-75.27%88.6M
-1.33%430.2M
11.50%642.6M
-7.27%576.3M
-40.35%241M
-19.97%358.3M
-20.44%436M
Current changes in cash
84.40%-32.7M
-905.02%-529.7M
-93.66%25.4M
98.37%-1.9M
-338.27%-343.6M
-49.71%-209.6M
246.55%65.8M
132.44%400.5M
-167.36%-116.3M
21.99%-78.4M
Effect of exchange rate changes
--0
-340.00%-1.2M
-236.36%-1.5M
210.00%1.1M
-185.71%-600K
33.33%-200K
266.67%500K
--1.1M
-400.00%-1M
250.00%700K
End cash Position
-81.64%79M
-82.62%111.7M
-82.62%111.7M
-63.57%87.8M
-75.27%88.6M
-1.33%430.2M
11.50%642.6M
11.50%642.6M
-40.35%241M
-19.97%358.3M
Free cash flow
63.13%-73.4M
-72.05%-257.9M
-70.09%20.7M
146.52%47.4M
-166.04%-126.9M
-186.47%-199.1M
-255.98%-149.9M
-75.49%69.2M
-164.68%-101.9M
50.67%-47.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 65.98%-62.6M-504.99%-206.3M-65.41%32.1M181.08%60M-633.33%-114.4M-393.30%-184M-110.65%-34.1M-71.72%92.8M-543.11%-74M47.47%-15.6M
Net income from continuing operations 104.83%9M-259.40%-760.5M26.12%-49.5M-215.62%-266.7M-357.62%-258.1M-4,932.43%-186.2M-196.40%-211.6M-137.66%-67M-158.41%-84.5M-1,326.09%-56.4M
Operating gains losses -------74.2M---3.7M--2M------------------------
Depreciation and amortization -19.36%27.9M-12.70%125.1M-17.09%29.6M-13.04%28M-26.07%32.9M11.97%34.6M15.75%143.3M22.26%35.7M-1.53%32.2M34.04%44.5M
Deferred tax -159.57%-12.2M68.88%-8.9M90.39%-5.2M-71.62%6.5M-885.71%-5.5M-347.37%-4.7M-162.17%-28.6M-219.16%-54.1M502.63%22.9M146.67%700K
Other non cash items 168.75%4.3M163.36%34.5M292.59%10.4M-77.60%2.8M405.13%19.7M-23.81%1.6M45.56%13.1M93.86%-5.4M-86.29%12.5M3,800.00%3.9M
Change In working capital -170.08%-97.5M-3,247.62%-70.3M-71.85%46.5M195.46%65.2M-608.25%-145.9M53.95%-36.1M98.55%-2.1M28.16%165.2M23.00%-68.3M73.42%-20.6M
-Change in receivables -2,023.08%-50M-118.29%-21.6M3.65%36.9M574.34%72.1M-3,430.00%-133.2M-97.23%2.6M829.01%118.1M-63.86%35.6M81.00%-15.2M105.21%4M
-Change in inventory 85.34%-4.5M101.05%600K-43.98%25.6M95.60%-1.2M127.17%6.9M38.72%-30.7M14.26%-57.1M631.40%45.7M-225.81%-27.3M-225.74%-25.4M
-Change in prepaid assets -33.33%-6M158.79%11.7M108.33%30M96.64%-500K-375.00%-13.3M72.89%-4.5M-358.44%-19.9M-76.96%14.4M71.56%-14.9M-136.84%-2.8M
-Change in payables and accrued expense -332.50%-34.6M31.90%-55.5M-170.51%-42.2M138.46%3M-120.85%-8.3M91.83%-8M-1,098.53%-81.5M-177.61%-15.6M-118.62%-7.8M304.10%39.8M
-Change in other working capital -153.33%-2.4M-114.36%-5.5M-104.47%-3.8M-164.52%-8.2M105.52%2M160.00%4.5M160.70%38.3M295.18%85.1M84.42%-3.1M-302.22%-36.2M
Cash from discontinued investing activities
Operating cash flow 65.98%-62.6M-504.99%-206.3M-65.41%32.1M181.08%60M-633.33%-114.4M-393.30%-184M-110.65%-34.1M-71.72%92.8M-543.11%-74M47.47%-15.6M
Investing cash flow
Cash flow from continuing investing activities 28.48%-10.8M155.68%212.3M74.89%-11.4M93.04%-18.9M902.80%257.7M53.11%-15.1M-70.15%-381.3M0.87%-45.4M-392.03%-271.6M52.09%-32.1M
Net PPE purchase and sale 28.48%-10.8M55.44%-51.6M51.69%-11.4M54.84%-12.6M61.06%-12.5M53.11%-15.1M48.33%-115.8M48.47%-23.6M49.46%-27.9M52.09%-32.1M
Net business purchase and sale ------270.2M--0--0----------0--0--0----
Net other investing changes ----97.63%-6.3M--0---------------265.5M---21.8M--------
Cash from discontinued investing activities
Investing cash flow 28.48%-10.8M155.68%212.3M74.89%-11.4M93.04%-18.9M902.80%257.7M53.11%-15.1M-70.15%-381.3M0.87%-45.4M-392.03%-271.6M52.09%-32.1M
Financing cash flow
Cash flow from continuing financing activities 487.62%40.7M-211.33%-535.7M-98.67%4.7M-118.75%-43M-1,485.99%-486.9M85.11%-10.5M441.28%481.2M420.42%353.1M4,686.00%229.3M-707.89%-30.7M
Net issuance payments of debt 589.29%41.1M-196.31%-543.4M-98.83%4.1M-118.68%-42.9M-5,807.14%-496.2M1.18%-8.4M1,671.59%564.2M4,284.52%351.5M4,200.00%229.6M-47.37%-8.4M
Net common stock issuance ----110.23%8.4M200.00%200K--0--------22.55%-82.1M99.81%-200K--0---24.4M
Proceeds from stock option exercised by employees -----64.00%1.8M-75.00%500K--0---------68.55%5M-41.18%2M--0-19.35%2.5M
Net other financing activities 80.95%-400K57.63%-2.5M50.00%-100K66.67%-100K50.00%-200K58.00%-2.1M60.67%-5.9M-120.00%-200K84.21%-300K66.67%-400K
Cash from discontinued financing activities
Financing cash flow 487.62%40.7M-211.33%-535.7M-98.67%4.7M-118.75%-43M-1,485.99%-486.9M85.11%-10.5M441.28%481.2M421.00%353.1M4,686.00%229.3M-707.89%-30.7M
Net cash flow
Beginning cash position -82.62%111.7M11.50%642.6M-63.57%87.8M-75.27%88.6M-1.33%430.2M11.50%642.6M-7.27%576.3M-40.35%241M-19.97%358.3M-20.44%436M
Current changes in cash 84.40%-32.7M-905.02%-529.7M-93.66%25.4M98.37%-1.9M-338.27%-343.6M-49.71%-209.6M246.55%65.8M132.44%400.5M-167.36%-116.3M21.99%-78.4M
Effect of exchange rate changes --0-340.00%-1.2M-236.36%-1.5M210.00%1.1M-185.71%-600K33.33%-200K266.67%500K--1.1M-400.00%-1M250.00%700K
End cash Position -81.64%79M-82.62%111.7M-82.62%111.7M-63.57%87.8M-75.27%88.6M-1.33%430.2M11.50%642.6M11.50%642.6M-40.35%241M-19.97%358.3M
Free cash flow 63.13%-73.4M-72.05%-257.9M-70.09%20.7M146.52%47.4M-166.04%-126.9M-186.47%-199.1M-255.98%-149.9M-75.49%69.2M-164.68%-101.9M50.67%-47.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg